Case Detail

Case Summary

Myriad: Breast Cancer Testing in Britain (B)

Case Number: 5-304-503(B), Year Published: 2004

HBS Number: KEL051

Request PreviewBuy

Authors: Daniel Diermeier; Shobita Parthasarathy

Key Concepts

Health Care, Genetic Testing, Patient Advocacy, Non-government organizations, Patenting, Global

Abstract

The case describes Myriad Genetics and its struggle to secure exclusive testing services for the BRCA gene. After Myriad obtained licensing rights and dissolved its U.S. competition, it turned its focus to Europe, specifically the UK. The UK National Health Service had made genetic testing available to the public and Myriad had to decide which course of action would be most effective in stopping British BRCA genetic testing and expanding Myriad’s own service to this new market.

Number of Pages: 14

Extended Case Information

Teaching Areas: Biotechnology, Management, Marketing, Strategy

Geographic: United Kingdom

Industry: Genetic Testing

Organization Name: Myriad Genetics

Organization Size: Small

Year of Case: 1995